Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07215884

Dopamine and Sensorimotor Function in Stuttering

Conditions: Stuttering, Adult

Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: Yes
Phase: PHASE1
Enrollment: 25
Sponsor: University of California, San Francisco

Location: Biomagentic Imaging Lab San Francisco California

Summary

This study is being done to understand the effect of aripiprazole on adults who stutter. Stuttering is a disorder that affects speech fluency. This study aims to understand sensorimotor pathways of stuttering and possible interventions.

Eligibility Criteria

Inclusion Criteria: * native speakers of American English * for adults who stutter, presence of stuttering will be confirmed, with onset before age 6 years * Normal hearing * Ages of 18 to 65 years * healthy adults without hearing-language difficulties Exclusion Criteria: * self-reported speech-language-hearing difficulties other than stuttering * self-reported neurological or psychological problems * other medications (drugs that affect dopaminergic system and/or benzodiazepines)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07215884). StuddyBuddy aggregates publicly available trial information.